Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

ELTXELTX
9 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in ELICIO THERAPEUTICS INC

Yes. Wells Fargo holds 11,823 shares of ELTX (Elicio Therapeutics), worth $46,228, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$46,228

Current Shares

11,823

Total Value Change

+$46,085

Total Shares Change

+11,808

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
11,823
-
$46,2280.0%$3.91
31
2026-Q1
Exited
0
-100.0%
$00.0%$10.69
0
2025-Q4
Unchanged
200
0.0%
$1,5920.0%$7.96
0
2025-Q3
New
200
-
$2,1880.0%$10.94
18
2024-Q2
Exited
0
-100.0%
$00.0%$4.11
0
2024-Q1
Increased
50
+16.3%
$3800.0%$7.60
9
2023-Q4
Increased
43
+95.5%
$3590.0%$8.34
12
2023-Q3
Increased
22
+46.7%
$1860.0%$8.45
10
2023-Q2
New
15
-
$1430.0%$9.50
17

Other major holders of ELTX: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used